Established in 1988, Tulip Diagnostics (P) Ltd comprises of eight independent diagnostic units has emerged as the leading manufacturer and marketer of in-vitro diagnostic reagents, kits and instruments both nationally and internationally.
Biospectrum, a widely acclaimed Biotech business magazine published by Cybermedia publication, India, in its issue 7, Vol 5, has rated Tulip Group of Companies as the No 1 diagnostic company in India.
Well known for its innovative approach, the group companies are owned, managed and run by highly involved professionals and has continuously set new trends through product development and improvements.
While Tulip Diagnostics (P) Ltd., focuses on assay systems for Immunohaematology, Hematology, Rheumatology, Infectious Diseases, Hemostasis and Instrumentation, its Division Microxpress focuses on Dehydrated Culture Media, Bases, Supplements, Reagent and Test kits, Sterile ready prepared plates, Antimicrobial Susceptibility discs, Plant tissue culture media and chemicals for Microbiology and Mycobacteriology. Orchid Biomedical Systems, Qualpro Diagnostics, Zephyr Biomedicals focuses on Rapid membrane & ELISA based immunodiagnostic platforms along with chemiluminescence. Viola Diagnostic Systems deals with Rapid immunoassays for Parasitology range and infectious diseases. Coral Clinical Systems focuses on Clinical Biochemistry and Instrumentation while its division BioShields deals with High Quality antiseptics and disinfectants for industrial, medical and domestic use.
Tulip Diagnostics (P) Ltd. currently has seven manufacturing sites in Goa and two in North India. The recent expansion of a plant in Uttarakhand, which is specifically for in vitro diagnostics, has been a major endeavor for Tulip during the year. Additionally, the company will also be making substantial facility additions in the times to come, depending on the demand.
All the companies are ISO 13485: 2003 compliant. The groups products are manufactured in professionally set up modern facilities complying with relevant FDA guidelines. Most of the products are CE certified with exports to over 96 countries across the world through organized distributor setup.
The companys national network business is built around 13 branch locations with more than 400 sales and service professionals headquartered all over the country to carry forward its customer contact and sales programme to a customer base of over 22,000 customers and 400 distributors.
Tulip Diagnostics (P) Ltd. has continuously evolved foraying into different ventures. Tulip Instruments Division was launched in the year 2000 to complement the Precision, Accuracy and Reliability of Tulip reagents. Since then semi-automated and automated Clinical chemistry Analysers, Turbidimetry Analysers, ELISA Processors, Coagulometers, Gel System Instruments, Microwell CLIA system, Osmomerty, Cell counters etc. that can perform reliably in domestic conditions, have been setup in major pathological laboratories and hospitals both in India and abroad. The Instruments Division has grown rapidly to over 9500 installations across the country and other parts of the world.
Tulip has always responded to user requirements, leading the forefront in development and introducing cutting edge technology based product platforms. Matrix™ Gel System based on gel column technology is one such venture. The recent introductions include rapid diagnostic tests for blood grouping, drugs of abuse and CLIA. Additionally enzymatic tests for biochemistry, new dehydrated culture media, plant tissue culture were also introduced into the market.
Sharp segmental focus through well-differentiated and dedicated research, production and sales teams ensures a flush new product pipeline and a wide user base for all Tulip products; both nationally and internationally.